Copper binding
GHK forms a stable complex with copper(II), potentially helping regulate copper availability in biological environments.
P—07 • Investigational research profile
GHK-Cu
A concise educational overview of a naturally occurring copper-binding tripeptide studied in extracellular-matrix biology, skin research, and wound response.
Name
GHK-Cu
Also known as copper tripeptide-1
- Scientific classification
- Naturally occurring glycyl-L-histidyl-L-lysine tripeptide complex coordinated with copper(II)
- Library family
- Regenerative
- Research status
- Investigational; mechanistic evidence is primarily preclinical, with limited topical human studies
- Regulatory status
- Not FDA approved as a therapeutic drug; non-injectable GHK-Cu is under FDA Category 1 evaluation, while injectable compounded GHK-Cu has route-specific safety concerns
Compound overview
A naturally occurring peptide complex that binds copper.
GHK is a three-amino-acid peptide found in human plasma and other biological fluids. It binds copper ions to form GHK-Cu.
Researchers study this complex because copper participates in connective-tissue formation, antioxidant defense, wound response, and numerous enzyme systems. GHK-Cu may help transport or regulate biologically available copper within tissue-repair environments.
Mechanism under study
Copper-associated extracellular-matrix signaling
GHK-Cu does not appear to act through one clearly established receptor. Laboratory research instead connects it with copper coordination, fibroblast activity, extracellular-matrix production, and controlled tissue remodeling.
Matrix production
Fibroblast experiments report increased collagen and glycosaminoglycan synthesis under defined laboratory conditions.
Matrix remodeling
GHK-Cu has influenced MMP-2 and tissue-inhibitor expression in cultured fibroblasts, suggesting involvement in extracellular-matrix turnover.
Its complete mechanism—and the clinical importance of its laboratory effects—remain under investigation.
Current research areas
Questions under investigation
- Skin and connective-tissue remodeling
- Collagen and extracellular-matrix regulation
- Wound-healing biology
- Fibroblast activity and cellular migration
- Topical delivery and age-related skin changes
Evidence summary
Matrix and wound-response findings
- Extracellular-matrix support: Laboratory studies report increased collagen and glycosaminoglycan production.
- Matrix remodeling: Fibroblast research suggests regulation of enzymes involved in breaking down and rebuilding extracellular matrix.
- Wound repair: A randomized controlled study evaluated a topical GHK-Cu gel in people with diabetic neuropathic ulcers and reported improved healing outcomes. This does not establish a general benefit for every formulation or condition.
- Skin research: GHK-Cu is studied in topical skin formulations, but evidence for broad anti-aging or cosmetic claims remains limited and formulation-dependent.
- Systemic research opportunity: Additional controlled human studies can clarify whether laboratory and topical findings translate to other research contexts.
The strongest current evidence comes from topical products, cell cultures, and wound-specific research, creating a focused foundation for broader studies.
Educational notice
Education, not usage guidance.
This profile is provided for scientific education only. It is not medical advice, treatment guidance, dosing information, or instructions for GHK-Cu use. Evidence and safety considerations differ substantially between topical and injectable routes. Injectable compounded GHK-Cu has limited human safety data and has been flagged by the FDA for potential immunogenicity and product-quality concerns.
Key scientific referencesComing soon
A curated primary-source reference list will be added during the next educational expansion.